Sumatriptan Succinate Tablets

The contract pertains to Sumatriptan Succinate Tablets under solicitation SPE2D223R0003, with the recent modification P00007 exercising Option Year Three, extending performance from July 25, 2026, through July 24, 2027. The award is managed by the Defense Logistics Agency Troop Support, part of the Department of Defense, and is headquartered in Philadelphia, Pennsylvania, with the primary point of contact being Nancy Fernandez. The product will be delivered to a place of performance in Carole Park, Australian Capital Territory, Australia, indicating international fulfillment. The North American Industry Classification System code 325412 confirms the manufacturing classification for pharmaceutical preparations. There is no set-aside designation applied to this award. Contact information for inquiries includes both primary and secondary points of contact with respective phone numbers and email addresses listed, and further details can be accessed through the SAM.gov portal.